Improved Metabolic Health: Beyond weight loss, these programs can improve blood sugar control and reduce risks associated with obesity, such as type 2 diabetes and cardiovascular disease
As longevity and preventative medicine become increasingly mainstream, some physicians and patients are exploring a different approach: microdosing, or using lower-than-standard doses of a GLP-1 under medical supervision
Studies, such as those published in the Journal of Clinical Endocrinology & Metabolism , highlight the multifaceted benefits of GLP-1 receptor agonists in weight management
Personalized GLP-1 GLP-1 is a prescription medication that is prescribed for Type 2 Diabetes
As prices become more affordable, these drugs could transform chronic disease management for millions
22 Eli Lilly and the Tirzepatide Portfolio: Manufacturing as a Moat While Novo Nordisk has focused heavily on the longevity of a single molecule, Eli Lillys strategy for tirzepatide (Mounjaro and Zepbound) is defined by clinical differentiation and an aggressive manufacturing moat